Home > Issues > Prescription drugs
 

Prescription drugs

Change Text Size:   Smaller Text Size   Larger Text Size   Default Text Size    

The following is a list of briefings, documents, and publications that have been ranked by the Alliance for Health Reform in order of relevance, 10 being "Exclusively Related" to the issue, to 5 being "Somewhat Related" to the issue. Webcasts, transcripts and resource materials can be downloaded for each briefing listed.
 
RankTypeDescription
10Briefing  Private Financing and High-level Functioning: Some International Approaches to Health Reform, 4/11/2008
While the United States delivers some of the best medical care in the world, there are major inefficiencies in our system. We have high rates of medical errors, millions without health insurance coverage, and lower utilization of advanced health information technology than most western European nations. What can we learn about coverage patterns and health care costs in other countries that might help inform our choices in the U.S.? This briefing, cosponsored by The Commonwealth Fund, addressed these and related questions.  
10Briefing  Reviewing Prescription Drug Coverage: Policies and Practices Across Several Health Systems, 6/23/2006
The Medicare prescription drug program offers coverage for prescription drugs through competing private plans, within a framework established by law and through rules established by the Centers for Medicare and Medicaid Services. In contrast, other countries, including Australia, the UK, and Canada, provide similar prescription drug programs, but within different regulatory structures. How do these countries decide which drugs will be approved and included in their prescription drug programs for the elderly and disabled?  
10Briefing  WEIGHING THE EVIDENCE: Conducting Reviews of Pharmaceuticals in Four Countries, 4/22/2005
Publicly funded health programs, large employers and managed care plans all are working to learn more about how the costs and benefits of one drug compare with those of another. At the same time, these payers of health care want to make sure that their beneficiaries have access to new pharmaceuticals that offer measurable improvements over older products. What evidence gets reviewed in deciding (or recommending) whether a drug gets covered? How open to public scrutiny is the review process? Which stakeholders are most closely involved? Are decisions ever revisited or reversed? How do review methods differ among different countries?  
10Briefing  The Reality and Potential of Evidence-Based Medicine, 1/12/2005
Evidence-based medicine offers a win-win proposition: improve the quality and effectiveness of care while at the same time identifying opportunities to reduce waste of valuable health care resources. But what evidence should employers, health care providers and consumers pay attention to? And how should this information be disseminated to those who need it? 
10Other PublicationSourcebook 2004 - Chapter 6: Prescription Drugs, 9/1/2004
This chapter from the Alliance sourcebook, “Covering Health Issues, 2004” presents key facts, background, story ideas, experts and websites on the subject of prescription drugs. (Adobe Acrobat PDF: 2,430 kb)
9Briefing  BALANCING THE PROMISE AND COST OF BIOTECHNOLOGY , 9/22/2006
Biotechnology accounts for only one percent of insurers’ costs, but those costs are growing at a double digit rate. As science produces increasingly sophisticated and expensive medical products and procedures based on the manipulation of living organisms, payers will increasingly struggle with managing their use.  
9Briefing  Making Sense of Medicare's Drug Benefit: Information and Resources to Help Beneficiaries, 11/7/2005
To help understand the basics of the new Medicare prescription drug benefit, the nonpartisan Alliance for Health Reform and the Kaiser Family Foundation held a briefing especially for congressional staff, including district and state staff, but also of interest to others. Panelists were Tricia Neuman of the Kaiser Family Foundation’s Medicare Policy Project; Jack Vogelsong of Pennsylvania’s State Health Insurance and Assistance Program; Beatrice Disman of the New York Region of the Social Security Administration; and Julie Goon of the Centers for Medicare and Medicaid Services.  
9Document  Letter to Baucus, 5/22/2008
 - Source: Various Drugstore Chains (Adobe Acrobat PDF: 116 kb)
9Document  Sourcelist, 4/11/2008
 - Source: Microsoft Word (Word Document: 52 kb)
9Document  Medicare Part D Fact Sheet, 10/29/2007
 - Source: Kaiser Family Foundation (Adobe Acrobat PDF: 332 kb)
9Document  Tracking Medicare Health and Prescription Drug Plans - Monthly Report for September 2007, 10/10/2007
 - Source: Kaiser Family Foundation and Mathematica Policy Research, Inc. (Adobe Acrobat PDF: 42 kb)
9Briefing TranscriptTranscript: Balancing the Cost and the Promise of Biotechnology, 9/22/2006
 (Adobe Acrobat PDF: 195 kb)
9Document  Steven Morgan Presentation: Well-Designed Drug Review Processes Can Improve Drug Coverage, 6/23/2006
 - Source: Centre for Health Services and Policy Research, U. of British Columbia (Adobe Acrobat PDF: 383 kb)
9Briefing TranscriptReviewing Prescription Drug Coverage, 6/23/2006
 - Source: Kaisernetwork.org (Adobe Acrobat PDF: 227 kb)
9Document  Australia's Nat'l Medicines Policy: Providing an Integrated Policy Platform for Pharmaceuticals, 6/23/2006
 - Source: Elizabeth Roughead, University of South Australia School of Pharmacy and Medical Sciences (Word Document: 104 kb)
9Document  Libby Roughead Presentation: Australia's National Medicines Policy, 6/23/2006
 - Source: University of South Australia (Adobe Acrobat PDF: 9,267 kb)
9Document  P. Kanavos Presentation: The European Experience in Drug Policy, Efficiency & Cost Containment, 6/23/2006
 - Source: London School of Economics (Adobe Acrobat PDF: 485 kb)
9Document  Tanisha Carino Presentation: The U.S. Perspective - Medicare Part D, 6/23/2006
 - Source: Avalere Health (Adobe Acrobat PDF: 245 kb)
9Document  Policy Approaches to Pharmaceutical Pricing and Reimbursement in European Countries, 6/23/2006
 - Source: Panos Kanavos, London School of Economics and Political Science (Word Document: 107 kb)
9Document  Centralized Drug Review in Australia, Canada, New Zealand and the United Kingdom, 6/23/2006
 - Source: Steven Morgan, University of British Columbia (Word Document: 74 kb)
9Document  Medicare's New Adventure: the Part D Drug Benefit, 3/1/2006
 - Source: The Commonwealth Fund (Adobe Acrobat PDF: 133 kb)
9Briefing TranscriptThe Reality and Potential of Evidence-Based Medicine, 1/12/2006
 - Source: Kaisernetwork.org (Adobe Acrobat PDF: 193 kb)
9Briefing TranscriptWeighing the Evidence: Conducting Reviews of Pharmaceuticals in Four Countries, 4/22/2005
 - Source: Alliance for Health Reform (Adobe Acrobat PDF: 211 kb)
9Document  Sourcelist: The Reality and Potential of Evidence-Based Medicine, 1/12/2005
 - Source: Alliance for Health Reform (Word Document: 28 kb)
9Document  Gail Shearer Presentation: Bringing Evidence-Based Medicine to Consumers, 1/12/2005
 - Source: Consumers Union (PowerPoint: 2,308 kb)
9Offsite Document  Q&As about the NIMH Clinical Antipsychotic Trials of Intervention Effectiveness Study (CATIE), 9/1/2005
 - Source: National Institute of Mental Health (Unknown File Type)
9Offsite Document  Q&As about the NIMH Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study , 3/23/2006
 - Source: National Institute of Mental Health (Unknown File Type)
9Offsite Document  Europe's Ailing Drug Industry, 12/28/2005
 - Source: Galen Institute (Unknown File Type)
9Offsite Document  Navigating the Medicare Part D Prescription Drug Coverage Program, 6/14/2006
 - Source: United Cerebral Palsy (Unknown File Type)
9Offsite Document  Pharmaceutical Pricing Policies and Innovation, 1/1/2006
 - Source: Organisation for Economic Co-operation and Development (Unknown File Type)
9Offsite Document  Centralized Drug Review Processes in Australia, Canada, New Zealand, and the United States, 4/1/2006
 - Source: Health Affairs (Unknown File Type)
9Offsite Document  Evidence-Based and Value-Based Formulary Guidelines, 2/1/2004
 - Source: Health Affairs (Unknown File Type)
9Offsite Document  The Efficient Use of Pharmaceuticals: Does Europe Have Any Lessons for a Medicare Drug Benefit?, 6/1/2003
 - Source: Health Affairs (Unknown File Type)
9Offsite Document  Herceptin - UK Employers Should Prepare for Rise in Healthcare Costs, 6/22/2006
 - Source: Mercer Human Resource Consulting (Unknown File Type)
9Offsite Document  Effective Health Care, 1/1/2006
 - Source: Agency for Healthcare Research and Quality (Unknown File Type)
9Offsite Document  Drug Effectiveness Review Project, 1/1/2006
 - Source: Oregon Health and Science University (Unknown File Type)
9Offsite Document  Comparative Effectiveness of Treatments for Low Bone Density (Including Osteoporosis), 1/1/2006
 - Source: Agency for Healthcare Research and Quality Adobe Acrobat PDF
9Offsite Document  Medicare Part D: Assessing the Impact for Beneficiaries Without Prev Drug Coverage and Dual Eli, 9/1/2007
 - Source: PhRMA Adobe Acrobat PDF
9Offsite Document  Medicare Part D Chartpack, 11/7/2007
 - Source: Kaiser Family Foundation (Unknown File Type)
9Offsite Document  Medicare Part D 2008 Data Spotlights, 11/7/2007
 - Source: Kaiser Family Foundation (Unknown File Type)
9Offsite Document  Minnesota Mandates E-Prescribing, 6/3/2008
 - Source: Health Data Management (Unknown File Type)
8Briefing  Health Legislation 2007-2008: What's Possible?, 12/13/2006
Suddenly, Capitol Hill is talking about health issues again. Incoming House Speaker Nancy Pelosi promises that Democrats will roll back the prohibition against the federal government negotiating drug prices on behalf of Medicare beneficiaries. (A Kaiser Family Foundation poll released today found broad bipartisan support for this idea.) Incoming Senate Majority Leader Harry Reid says one of his three top priorities will be more funding for stem cell research. Others want to revisit the importation of prescription drugs from Canada. Additionally, the 110th Congress will consider whether to continue the State Children’s Health Insurance Program in its present form.  
8Briefing  Implementing the Medicare Drug Benefit: The Stories Ahead, 9/27/2005
Medicare beneficiaries can start signing up for prescription drug plans on November 15. Already, health plans have announced that they will be spending up to $80 million each to promote their offerings. The federal government and nonprofit groups are well into a massive effort to educate the public. But beneficiaries and those they rely on still have many questions about the program. The Alliance for Health Reform sponsored a briefing on Sept. 27 to help reporters with their coverage of the new benefit's implementation and offer story ideas. 
8Document  The Power of Partnerships: Lessons from Outreach for the Part D Low-Income Subsidy Program, 9/1/2007
 - Source: Kaiser Permanente (Adobe Acrobat PDF: 554 kb)
8Document  Using Clinical Evidenceto Manage Pharmacy Benefits: Experiences of Six States, 3/1/2007
 - Source: The Commonwealth Fund (Adobe Acrobat PDF: 133 kb)
8Document  AHIP Statement on Medicare Part D, 1/1/2007
 - Source: America's Health Insurance Plans (Adobe Acrobat PDF: 66 kb)
8Document  Robinson Presentation: Balancing the Promise and Cost of Biotechnology, 9/22/2006
 (Adobe Acrobat PDF: 81 kb)
8Document  Tunis Presentation: Balancing the Promise and Cost of Biotechnology, 9/22/2006
 (Adobe Acrobat PDF: 168 kb)
8Document  Health Care Opinion Leaders Survey: Medicare Part D, 7/6/2006
 - Source: The Commonwealth Fund (Adobe Acrobat PDF: 63 kb)
8Document  Sourcelist: Reviewing Prescription Drug Coverage, 6/23/2006
 - Source: Alliance for Health Reform (Word Document: 41 kb)
8Document  Tricia Neuman Presentation: The Medicare Prescription Drug Benefit, 11/7/2005
 - Source: Kaiser Family Foundation (Adobe Acrobat PDF: 75 kb)
8Briefing TranscriptMaking Sense of Medicare's Drug Benefit, 11/7/2005
 - Source: Kaisernetwork.org (Adobe Acrobat PDF: 208 kb)
8Document  Sourcelist: Weighing the Evidence- Conducting Reviews of Pharmaceuticals in Four Countries, 4/22/2005
 - Source: Alliance for Health Reform (Word Document: 31 kb)
8Offsite Document  Principles for Govt-Supported Health Outcomes Research on Medical Technologies & Services, 1/1/2006
 - Source: PhRMA (Unknown File Type)
8Offsite Document  Average Medicare Prescription Drug Premiums to Rise 21%, 10/5/2007
 - Source: Avalere Health (Unknown File Type)
8Offsite Document  Electronic Prescribing: Becoming a Mainstream Practice, 6/10/2008
 - Source: eHealth Initiative and Center for improving Medication Management Adobe Acrobat PDF
8Offsite Document  E-prescribing Campaign Aims at Patients to Reach Doctors, 6/2/2008
 - Source: American Medical News (Unknown File Type)
7Document  2007 State of the Union Policy Initiatives: Affordable, Accessible, And Flexible Health Covera, 1/1/2007
 - Source: The White House (Word Document: 50 kb)
7Document  Comparitive Effectiveness Forum: Executive Summary, 11/30/2006
 - Source: The Health Industry Forum (Adobe Acrobat PDF: 465 kb)
7Document  Drug Money, 6/16/2006
 - Source: Christopher Gallen, Canadian Business (Word Document: 30 kb)
7Document  CMS Sets $500 Threshold for Specialty Tiers, 4/1/2006
 - Source: Medicare Drug Reimbursement Guide  (Adobe Acrobat PDF: 393 kb)
7Document  418 Biotechnology Medicines in Testing Promise to Bolster the Arsenal Against Disease, 1/1/2006
 - Source: Pharmaceutical Research and Manufacturers Association (PhRMA) (Adobe Acrobat PDF: 254 kb)
7Document  Australia's Centralized Cost-Effectiveness Requirement for Pharmaceuticals, 1/1/2006
 - Source: IMS Consulting (Adobe Acrobat PDF: 139 kb)
7Document  As biotech drug prices rise, U.S. hunts for solution, 12/28/2005
 - Source: Geeta Anand, The Wall Street Journal (Word Document: 45 kb)
7Document  Julie Goon Presentation: CMS Information and Resources for the Medicare Drug Benefit, 11/7/2005
 - Source: CMS (Adobe Acrobat PDF: 1,271 kb)
7Document  Sourcelist: Making Sense of Medicare's Drug Benefit, 11/7/2005
 - Source: Alliance for Health Reform (Word Document: 61 kb)
7Document  Mark Benoff Presentation: Implementing the Medicare Drug Benefit, 9/27/2005
 - Source: Cambridge Pharma Consultancy (Adobe Acrobat PDF: 126 kb)
7Document  Sourcelist: Implementing the Medicare Drug Benefit, 9/27/2005
 - Source: Alliance for Health Reform (Word Document: 101 kb)
7Briefing TranscriptImplementing the Medicare Drug Benefit, 9/27/2005
 - Source: Kaisernetwork.org (Adobe Acrobat PDF: 164 kb)
7Document  2005 International Symposium on Health Care Policy: Descriptions of Health Care Systems, 1/1/2005
 - Source: The Commonwealth Fund (Adobe Acrobat PDF: 136 kb)
7Offsite Document  Frist Highlights AHRQ's Efforts to Improve Quality of Health Care, 2/9/2006
 - Source: Bill Frist, M.D. United States Senator, Tennessee (Unknown File Type)
7Offsite Document  Consumer Reports Medical Website Gives Evidence & Treatment Ratings to Make Informed Decisions, 5/17/2005
 - Source: Consumer Reports (Unknown File Type)
7Offsite Document  Developing a Center for Comparative Effectiveness Information, 11/1/2006
 - Source: Health Affairs (Unknown File Type)
7Offsite Document  Consumer Reports: Best Buy Drugs, 4/27/2007
 - Source: Consumer Report (Unknown File Type)
7Offsite Document  Drug Effectiveness Review, 4/27/2007
 - Source: Oregon Health Science University (Unknown File Type)
6Briefing  Prospects for Health Care: Where Will New Congressional Leadership Take Us?, 12/8/2006
Come January, we can expect to see some new approaches to health legislation. Sen. Harry Reid, incoming Senate majority leader, says one of his top three priorities will be more funding for stem cell research. House Speaker-to-be Nancy Pelosi wants a vote early on to roll back the prohibition against the federal government negotiating prescription drug prices for Medicare beneficiaries. And these are just two of the health issues likely to be debated in the new Congress. The White House too will have a definite voice in the debates to come. 
6Briefing TranscriptWhat Other Nations Can Teach Us About A More Patient Centered Health Care System, Part I, 11/4/2006
 - Source: Kaisernetwork.org (Adobe Acrobat PDF: 143 kb)
6Briefing TranscriptWhat Other Nations Can Teach Us About A More Patient Centered Health Care System, Part II, 11/4/2006
 - Source: Alliance for Health Reform  (Adobe Acrobat PDF: 110 kb)
6Briefing TranscriptWhat Other Nations Can Teach Us About A More Patient Centered Health Care System, Part III, 11/4/2006
 - Source: Alliance for Health Reform  (Adobe Acrobat PDF: 132 kb)
6Document  New Study Captures Variations Across Medicare Drug Plans, 4/11/2006
 - Source: Kaiser Family Foundation  (Word Document: 56 kb)
6Document  The U.S. Health Care Divide: Disparities in Primary Care Experiences by Income, 4/1/2006
 - Source: The Commonwealth Fund (Adobe Acrobat PDF: 216 kb)
6Document  Mirror, Mirror on the Wall: Update on the Quality of American Health Care , 4/1/2006
 - Source: The Commonwealth Fund (Adobe Acrobat PDF: 191 kb)
6Document  The Rise and Role of Specialty Pharmacies, 10/1/2005
 - Source: David Suchanek, Biotechnology Healthcare (Adobe Acrobat PDF: 114 kb)
6Document  Aetna Letter: Health Savings Accounts - Exceptions for Preventive Prescription Drugs, 5/25/2005
 - Source: Aetna (Adobe Acrobat PDF: 325 kb)
6Offsite Document  Taking the Pulse of Health Care Systems: Experiences of Patients in Six Countries, 11/3/2005
 - Source: Health Affairs (Unknown File Type)
6Offsite Document  Squeezed: Why Rising Exposure to Health Care Costs Threatens the Health and Financial Well-Bein, 10/1/2006
 - Source: The Commonwealth Fund (Unknown File Type)
6Offsite Document  Candidates Issue Index, 5/13/2008
 - Source: The Brookings Institution (Unknown File Type)
5Document  Marsha Gold Presentation: What We Know From Analyzing Public Data Files, 5/19/2006
 - Source: Mathematica Policy Research, Inc.  (Adobe Acrobat PDF: 692 kb)
5Offsite Document  American College of Cardiology Supports E-Prescription Mandate, 6/3/2008
 - Source: iHealth Beat (Unknown File Type)
5Offsite Document  Details on Medicare Prescription Drug Deal Remain Murky, 7/13/2009
 - Source: Commonwealth Fund  (Unknown File Type)

 

Related Links

50 Ways to Implement Health Reform: State Challenges and Federal Assistance


What challenges need to be overcome by the states to implement various provisions in the health reform law? This briefing, cosponsored by the Robert Wood Johnson Foundation, looked into how the states and the federal government are working together to implement the law -- both near-term provisions, such as high-risk pools, as well as other provisions farther down the road, such as setting up exchanges and instituting changes to Medicaid eligibility.

Read More

New Toolkit -- Fresh Ideas for Reporting on Health Reform


Now that health reform is law, reporters covering this subject have a new challenge: keeping readers, viewers and listeners engaged through the long implementation process. This new toolkit from the Alliance for Health Reform will help. Features story ideas from seasoned reporters and links to dozens of resources. Also included: list of experts with contact information and helpful websites. To download, click here.

Read More 

Completely updated -- "Covering Health Issues" guide


"Covering Health Issues," the Alliance's popular 246-page guide to key health policy topics, has been completely updated. Each chapter now reflects the relevant provisions of the Patient Protection and Affordable Care Act. To see the table of contents, click here.

Read More 


New Issue Brief -- The Future of Children's Health Coverage


This issue brief details the children's coverage expansions in the new health reform law and also the law's potential to strain existing coverage programs for children. Written by Lisa Swirsky of the Alliance for Health Reform and supported by the Robert Wood Johnson Foundation. To download, click here.

Read More 

Toolkit-- Legal Challenges to the Health Reform Law


Twenty-one states and the National Federation of Independent Business have filed lawsuits challenging the new health reform law's constitutionality. On what grounds do reform opponents challenge the new law? What are the chances that any of these lawsuits might succeed? This toolkit from the Alliance for Health Reform, written by the Alliance’s Kevin Arts, addresses both questions. Includes key facts, background, links to specially selected articles and a list of experts with contact information. To download, click here.

Read More 

Copyright 1997-2010 Alliance for Health Reform
1444 Eye Street, NW, Suite 910 Washington, DC 20005-6573      202-789-2300      202-789-2233 fax      info@allhealth.org      Sitemap